Press release
Biosimilars Market 2025 Rising Trends and New Technologies Research Report with Teva Pharmaceutical Industries, Pfizer, Biocon, Samsung BioLogics, Mylan N.V., Amgen, Celltrion
Biosimilars Market to 2025
A biosimilar is a biological product which is similar to an FDA approved biologic product of another manufacturer. Owing to the complexities associated with development & manufacture of biosimilar products, these are manufactured by companies with highly skillful workforce and deep scientific expertise. The FDA approval process for biosimilar products is rigorous and enables high safety to the end users.
Ask for a Sample of this Report Now at: https://tinyurl.com/y4u2h86e
Biosimilars Market to 2025 - Global Analysis and Forecasts by Product (Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins, Peptides and Others); and Application (Oncology, Autoimmune Diseases, Chronic Diseases, Blood Disorders, Infectious Diseases, Growth Hormone Deficiency and Others)
Key Benefits-
• To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global Biosimilars Market
• To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)
Some of the key players influencing the market are Teva Pharmaceutical Industries Ltd., Pfizer Inc., Biocon, Samsung BioLogics, Mylan N.V., Amgen Inc., Celltrion, Healthcare Co.,Ltd., Sandoz International GmbH, STADA Arzneimittel AG, Dr. Reddy’s Laboratories Ltd. and others.
The growth of the global biosimilars market can be attributed to the growing demand of pharmaceutical drug supplements, especially for the high priced patented drugs expected to upsurge the growth of the market. Additionally, increasing incidences of chronic diseases add novel opportunities for the global biosimilars market over the forecast period.
The “Global Biosimilars Market Analysis to 2025” is a specialized and in-depth study of the healthcare industry with a focused global market trend. The report aims to provide an overview of global biosimilars market with detailed market segmentation by product, application, end user and geography. The global biosimilars market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
On the basis of product the market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, peptides and others. The recombinant non-glycosylated proteins market is further segmented into insulin, recombinant human growth hormone, granulocyte colony-stimulating factor and interferons. The recombinant glycosylated proteins segment is bifurcated into monoclonal antibodies and erythropoietin. The peptides segment is also classified into calcitonin and glucagon. Based on application the market is segmented into oncology, autoimmune diseases, chronic diseases, blood disorders, infectious diseases, growth hormone deficiency and others.
The report provides a detailed overview on the industry including both qualitative and quantitative information. It provides overview and forecast of the global biosimilars based on product and application. It also provides market size and forecast till 2025 for overall biosimilars market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East &Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 countries globally along with current trend and opportunities prevailing in the region.
Direct Purchase a Copy of this Report at: https://tinyurl.com/yyt4gltd
About Us
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
We are committed to providing highest quality research and consulting services to our customers. We help our clients understand key market trends, identify opportunities, and make informed decisions by providing market research solutions at an affordable cost.
Contact us
The Insight partners,
Phone: +1-646-491-9876
Email: sales@theinsightpartners.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biosimilars Market 2025 Rising Trends and New Technologies Research Report with Teva Pharmaceutical Industries, Pfizer, Biocon, Samsung BioLogics, Mylan N.V., Amgen, Celltrion here
News-ID: 1639124 • Views: …
More Releases from The Insight Partners
Photocurable Resins Market Forecast to 2031 Highlights Emerging Opportunities
The global photocurable resins market is gaining increasing attention as industries seek materials that support speed accuracy and consistent performance. Photocurable resins cure quickly under controlled light exposure enabling efficient production processes and superior finish quality. These advantages have led to growing adoption across sectors such as electronics healthcare printing and industrial manufacturing.
Industry participants are focusing on developing advanced resin systems that meet evolving technical and regulatory requirements. Enhanced material…
Organic Snacks Market Witnesses Surge in Health-Conscious Choices Amid Rising De …
United States of America - January 14, 2025 - The organic snacks market continues to flourish as consumers worldwide prioritize nutritious, sustainable snacking options free from synthetic additives and GMOs. Driven by heightened awareness of wellness and environmental impact, leading companies are innovating with flavorful, plant-based offerings that blend taste with health benefits.
Get a Sample Copy At - https://www.theinsightpartners.com/sample/TIPRE00019545/?utm_source=OpenPR&utm_medium=10826
This boom reflects a broader shift toward mindful eating habits, where organic…
Allnex Belgium SA/NV Leads Innovation in Saturated Polyester Resin Market with N …
United States of America - January 14, 2025 - According to The Insight Partners, The Saturated Polyester Resin Market is expected to register a CAGR of 5% from 2025 to 2031. The saturated polyester resin market continues to evolve as key players like Allnex Belgium SA/NV (formerly Cytec) announce strategic expansions to meet rising demand across automotive, building and construction, paints and coatings, and electrical and electronics sectors. This development…
Feed Grade Mono Calcium Phosphate (MCP) Market Forecast to 2031 - Trends, Segmen …
With livestock farming intensifying globally to meet growing demand for meat, dairy, and related animal‐products, feed additives have become central to maintaining animal health, growth, and productivity. One such additive, Feed Grade Mono Calcium Phosphate , is especially important for supplying calcium and phosphorus in feed. According to reports from The Insight Partners, the MCP market is set for robust growth from now through 2031.
Check valuable insights in the…
More Releases for Biosimilars
Transformative Trends Impacting the Biosimilars Market Landscape: Innovative Pro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Biosimilars Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The dimensions of the biosimilars market have been rapidly expanding over the last couple of years. The escalation, from a worth of $18.65 billion in 2024 to an estimated value of $21.95 billion in 2025, denotes…
Evolving Market Trends In The Biosimilars Industry: Innovative Product Launched …
The Biosimilars Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Biosimilars Market Size During the Forecast Period?
The dimension of the biosimilars market has experienced substantial expansion in the last few years. The market value, which was at $18.65 billion in 2024,…
Prominent Rituximab Biosimilars Market Trend for 2025: Collaborative Innovations …
Which drivers are expected to have the greatest impact on the over the rituximab biosimilars market's growth?
The rituximab biosimilars market is anticipated to grow due to the projected increase in non-Hodgkin's lymphoma (NHL) cases. NHL is a cancer that originates in the white blood cells and lymphocytes, which are integral parts of the body's immune system. For example, the American Cancer Society, a cancer advocacy group based in the US,…
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure.
According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is…
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased.
According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was…
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million…
